v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (4,336,007) $ (3,569,324)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 886,998 1,208,944
Depreciation 6,844
Amortization 27,061 9,912
Gain on sale of short-term investments (29,041) (52,557)
Return on investment in Joint Venture 864
Changes in operating assets and liabilities:    
Accounts receivable 28,641 (49,805)
Accounts receivable - related party 3,007
Prepaid expenses and other current assets (207,742) 50,086
Inventory (101,989) 1,604
Accounts payable (5,131) 84,631
Accrued expenses 215,750 (30,741)
Net cash used in operating activities (3,514,616) (2,343,379)
Cash flows from investing activities:    
Proceeds from sales and maturities of short-term investments 8,098,254 17,701,000
Purchase of short-term investments (5,001,190) (20,103,127)
Purchase of equipment (49,276)
Purchase of patents (42,476) (35,215)
Purchase of trademarks (35,307) (8,841)
Net cash provided by (used in) investing activities 2,970,005 (2,446,183)
Cash flows from financing activities:    
Sale of common stock for cash, net of financing fees 4,646,397
Net proceeds from sales of common stock under ATM program 894,786
Net cash provided by financing activities 894,786 4,646,397
Net increase (decrease) in cash and cash equivalents 350,175 (143,165)
Cash and cash equivalents - beginning of period 654,783 574,485
Cash and cash equivalents - end of period 1,004,958 431,320
Non-cash investing and financing activities:    
Acquisition of licensed technology through issuance of common stock and deferred share obligation 724,591
Remeasurement of deferred share consideration capitalized to acquired licensed technology (11,721)  
Unrealized gain (loss) on short-term investments $ (406) $ 1,343